Hims Hers Health IncHIMS
▼ NegativeRegulationPricingrelevance
FTC lawsuit alleges data sharing and billing issues, defended by CEO.
Impact on stocks 2
Health Care
Hims Hers Health IncSpatial Computing / AR/VR
Meta Platforms Inc.META
Mentioned
Hims & Hers Health CEO Andrew Dudum defended the company against a Federal Trade Commission lawsuit, saying the agency's decision to sue reflected a desire for publicity rather than a genuine resolution. Dudum told CNBC that the company had worked with the FTC for years and that the agency ultimately wanted a headline more than a real agreement. The FTC, joined by Los Angeles County and Utah, filed the lawsuit in July alleging Hims & Hers shared user health data with advertisers, billed customers before they spoke with a provider, and made cancellations difficult. Dudum also addressed the company's shift away from compounded GLP-1 weight loss drugs toward branded medications, anticipating cash-paying patients will eventually see monthly costs drop to between $40 and $50 from a current range of around $150 to $200. The interview came days after Hims & Hers reported a net loss of $86.3 million in the second quarter of 2026, compared with net income of $42.5 million a year earlier, while revenue rose 38% to $753.2 million and full-year guidance was raised to a range of $3.1 billion to $3.3 billion.
Hims Hers Health IncFTC lawsuit alleges data sharing and billing issues, defended by CEO.
Meta Platforms Inc.